SIMULTANEOUS APPLICATION OF BEVACIZUMAB AND ANTI-CTGF ANTIBODY EFFECTIVELY SUPPRESSES PROANGIOGENIC AND PROFIBROTIC FACTORS IN HUMAN RPE CELLS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BAGHERI A.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: MOLECULAR VISION Year:2015 | Volume:21 | Issue:- Page(s): 378-390

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

SIMULTANEOUS APPLICATION OF BEVACIZUMAB AND ANTI-CTGF ANTIBODY EFFECTIVELY SUPPRESSES PROANGIOGENIC AND PROFIBROTIC FACTORS IN HUMAN RPE CELLS

Author(s)

BAGHERI A. | Issue Writer Certificate

Keywords

Not Registered.

Abstract

Cites

OCULAR SAFETY OF INTRAVITREAL ANTI CONNECTIVE TISSUE GROWTH FACTOR NEUTRALIZING ANTIBODY

References

No record.

Cite

APA: Copy

BAGHERI, A.. (2015). SIMULTANEOUS APPLICATION OF BEVACIZUMAB AND ANTI-CTGF ANTIBODY EFFECTIVELY SUPPRESSES PROANGIOGENIC AND PROFIBROTIC FACTORS IN HUMAN RPE CELLS. MOLECULAR VISION, 21(-), 378-390. SID. https://sid.ir/paper/707981/en

Vancouver: Copy

BAGHERI A.. SIMULTANEOUS APPLICATION OF BEVACIZUMAB AND ANTI-CTGF ANTIBODY EFFECTIVELY SUPPRESSES PROANGIOGENIC AND PROFIBROTIC FACTORS IN HUMAN RPE CELLS. MOLECULAR VISION[Internet]. 2015;21(-):378-390. Available from: https://sid.ir/paper/707981/en

IEEE: Copy

A. BAGHERI, “SIMULTANEOUS APPLICATION OF BEVACIZUMAB AND ANTI-CTGF ANTIBODY EFFECTIVELY SUPPRESSES PROANGIOGENIC AND PROFIBROTIC FACTORS IN HUMAN RPE CELLS,” MOLECULAR VISION, vol. 21, no. -, pp. 378–390, 2015, [Online]. Available: https://sid.ir/paper/707981/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops